December 2, 2025 – TheNewswire - Vancouver, British Columbia, Canada -  Neurothera Labs Inc. (TSXV: NTLX) (“Neurothera” or the “Company”), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), today announced that it has entered into a non-binding term sheet (the “Term Sheet”) with a pioneering quantum computing bio data company focused on quantum-enabled clinical analytics (the “Target Company"). Under the terms of the Term Sheet, Neurothera will acquire a 55% eq ...